Board of Governors
Debra Barksdale, PhD, RN, is Associate Professor at the University of North Carolina (UNC) at Chapel Hill School of Nursing in Chapel Hill, NC. She is a researcher, certified nurse practitioner, and educator. Her research program focuses on psychological and physical stress, coping, and cardiovascular responses in African Americans. She is also a research fellow of the UNC Center for Health Promotion and Disease Prevention and a member of the Center’s Prevention Steering Committee. She is President-elect of the National Organization of Nurse Practitioner Faculty, a Fellow of the American Academy of Nurse Practitioners, and a volunteer family nurse practitioner in a clinic for the homeless. She is also a US Department of Health and Human Services Primary Health Care Policy Fellow. She received a BS in nursing from the University of Virginia, a master of science in nursing from Howard University, a post-masters in teaching from the University of Pennsylvania, and a PhD in Nursing Research from the University of Michigan.
Kerry Barnett, JD, is Executive Vice President, Corporate Services, Chief Legal Officer, and Ethics and Compliance Officer for Cambia Health Solutions, a nonprofit parent and holding company overseeing a diverse portfolio of health care businesses and investments ranging from traditional health insurance products to specialized services for innovation in health care engagement. Cambia is based in Portland, Oregon, and serves members across Oregon, Washington, Utah, and Idaho. Prior to joining Cambia, he was Senior Vice President for Medical Services with ODS Health Plans and Chief Executive Officer of HealthFirst Medical Group, PC. He also served as Oregon’s insurance commissioner and as the governor’s legal counsel and senior policy advisor. He is on the Public Policy Committee and Strategic Communications Advisory Council of America’s Health Insurance Plans. He received a BA in English from the University of Rochester and a JD from Yale Law School.
Lawrence Becker is Director of Strategic Partnerships and Alliances for Xerox Corporation in Rochester, NY, and is responsible for Global HR Vendor Optimization. He is also Chairman of the Plan Administration Committee for Xerox’s ERISA plans. Since joining Xerox, he has served in several capacities in the benefits, compensation, technology, and operations arenas including as director of benefits. He previously served as vice president of human resources for Baltimore Bancorp and worked for Formica Corporation, Exxon Corporation, and American Can Company in a variety of roles. He is a member of the Executive Board of ERIC (ERISA Industry Council), a member of the Board of Directors and Finance and Audit Committee of the National Quality Forum (NQF) as well as the NQF Steering Committee on Measuring Efficiency across Patient-Focused Episodes of Care. Additionally, he was a member of the Quality Alliance Steering Committee Expansion Workgroup commissioned by the Secretary of Health and Human Services. He is a board member of the Rochester Regional Health Information Operation. He received a BS from Cornell University’s Industrial and Labor Relations School.
Carolyn M. Clancy, MD, was appointed Director of the Agency for Healthcare Research and Quality (AHRQ) on February 5, 2003, and reappointed on October 9, 2009. Prior to her appointment, Dr. Clancy was Director of AHRQ’s Center for Outcomes and Effectiveness Research. Dr. Clancy, a general internist and health services researcher, is a graduate of Boston College and the University of Massachusetts Medical School. Following clinical training in internal medicine, Dr. Clancy was a Henry J. Kaiser Family Foundation Fellow at the University of Pennsylvania. Before joining AHRQ in 1990, she was also an assistant professor in the Department of Internal Medicine at the Medical College of Virginia. Dr. Clancy holds an academic appointment at George Washington University School of Medicine (Clinical Associate Professor, Department of Medicine) and serves as Senior Associate Editor, Health Services Research. She serves on multiple editorial boards including the Annals of Internal Medicine, Annals of Family Medicine, American Journal of Medical Quality, and Medical Care Research and Review. She is a member of the Institute of Medicine and was elected a Master of the American College of Physicians in 2004. In 2009, was awarded the 2009 William B. Graham Prize for Health Services Research. Her major research interests include improving health care quality and patient safety, and reducing disparities in care associated with patients’ race, ethnicity, gender, income, and education. As Director, she launched the first annual report to the Congress on health care disparities and health care quality.
Francis S. Collins, MD, PhD, has served as the Director of the National Institutes of Health (NIH) since August 17, 2009. Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, which successfully completed the first sequence of the human DNA instruction book in 2003. Dr. Collins received a B.S. in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University, and an M.D. with honors from the University of North Carolina at Chapel Hill. Prior to coming to the NIH in 1993 to lead the National Human Genome Research Institute, he spent nine years on the faculty of the University of Michigan. He is an elected member of the Institute of Medicine and the National Academy of Sciences. Dr. Collins was awarded the Presidential Medal of Freedom in 2007 and the National Medal of Science in 2009. On April 22, 2010, Dr. Collins was a co-recipient of the Albany Medical Center Prize in Medicine and Biomedical Research.
Allen Douma, MD, is Chief Executive Officer of Empower, LLC, in Ashland, OR, and a member of the AARP Board of Directors. Previously, he served as assistant director of the Oregon Department of Human Services, chief executive officer of Health Responsibility Systems, medical director for Hartford and Travelers Insurance Cos., assistant professor of CME at George Washington University, and director of Health Education for the American Medical Association. He serves on AARP’s Member and Social Impact Committee and the AARP Insurance Trust. He currently serves on the Boards of the Jefferson Regional Health Alliance and PRS Affordable Housing. He was a Robert Wood Johnson Foundation clinical scholar. He received a BES (engineering science) from The Johns Hopkins University and a MD from the Medical College of Virginia.
Arnold Epstein, MD, is the John H. Foster Professor and Chair of the Department of Health Policy and Management at Harvard University School of Public Health in Boston, MA. He is a practicing internist in the Department of Medicine at the Brigham and Women’s Hospital. His research interests focus on quality of care and access to care for disadvantaged populations. Recently, his efforts have focused on public reporting of quality performance data, racial and ethnic disparities in care, and policy changes that affect the quality and efficiency of hospital care. He was vice chair of the Institute of Medicine Committee on Developing a National Report on Health Care Quality. He also served as chairman of the board of AcademyHealth. He was Co-chair of the Performance Measurement Coordinating Council of the Joint Commission on Accreditation of Healthcare Organizations, the National Committee on Quality Assurance, and the American Medical Association. He is Associate Editor of the New England Journal of Medicine, is a member of the Institute of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation, and has served on several editorial boards including Health Services Research and the Annals of Internal Medicine. He received a BA from the University of Rochester, a masters in political science from Harvard, a BMS from Dartmouth Medical School and a MD from Duke University.
Christine Goertz, DC, PhD, is Vice Chancellor for Research and Health Policy at Palmer College of Chiropractic and Palmer Center for Chiropractic Research in Davenport, IA, where her research focuses on quality of outcomes for patients and the importance of provider collaboration in providing high-quality health care. Her work is focused on sub-acute and chronic lower back pain in adult populations. For over 20 years, she has addressed multidisciplinary science and health policy issues at the state and federal levels, serving as a member of the American Medical Association’s Measures Implementation and Evaluation Advisory Committee, Chair of the American Chiropractic Association’s Performance Measurement Task Force, and a program officer of the NIH National Center for Complementary and Alternative Medicine managing a portfolio focused on musculoskeletal disease, pain and health services research. She is a Fellow of the International College of Chiropractors. She received her doctor of chiropractic from Northwestern Health Sciences University and a PhD in Health Services Research Policy and Administration from the University of Minnesota.
Leah Hole-Marshall, JD, is the Program Director for the Health Technology Assessment (HTA) program of the Washington State Health Care Authority in Olympia, WA. This program relies on partnerships with public and private sector entities to ensure that medical treatments and services paid for with state health care dollars are safe and proven to work. HTA takes suggestions from state agency directors, and patient, physician and health industry groups regarding services for evaluation, and engages independent and impartial research firms to review evidence about safety and effectiveness of these services. Ms. Hole-Marshall has also led efforts to encourage patients and providers to use reliable clinical information to enhance the quality and safety of patient care. She served on the governing committee of the Medicaid Evidence-based Decisions Project at the Center for Evidence-based Policy at Oregon Health and Science University. She received a BA from Evergreen State College and a JD from Seattle University.
Conflict of Interest Disclosures
Gail Hunt is the President and CEO of the National Alliance for Caregiving, a non-profit coalition dedicated to conducting research and developing national programs for family caregivers and the professionals who serve them. Prior to heading NAC, as president of her own aging services consulting firm for 14 years, she conducted corporate eldercare research for the National Institute on Aging and the Social Security Administration, developed training for caregivers with AARP and the American Occupational Therapy Association, and designed a corporate eldercare program for the Employee Assistance Professional Association. Prior to having her own firm, she was a Senior Manager in charge of human services for the Washington, DC, office of KPMG Peat Marwick.
Robert Jesse, MD, PhD, is the Principal Deputy Under Secretary for Health, Department of Veterans Affairs (VA) in Washington, DC. He leads clinical policies and programs for VA, the Nation’s largest integrated health care system. He is Professor of Internal Medicine and Cardiology at Virginia Commonwealth University School of Medicine. He has extensive experience in comparative effectiveness, cardiology, cancer, and biochemical research. Previously, he was Chief Consultant for Medical Surgical Services in VA’s Office of Patient Care Services where he was instrumental in implementing broad reforms in the delivery of specialty, sub-specialty and emergency care. Dr. Jesse received his BS in Biochemistry from the University of New Hampshire and a PhD in Biophysics and MD at the Medical College of Virginia.
Harlan Krumholz, MD, is the Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine in New Haven, CT, and is a practicing cardiologist. He serves as Director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE) and as Director of the Robert Wood Johnson Clinical Scholars Program at Yale. His work in outcomes research focuses on determining optimal clinical strategies and improving the prevention, diagnosis and treatment of cardiovascular disease. He serves on the Board of Trustees of the American College of Cardiology and on the Board of Directors of the American Board of Internal Medicine and is a member of the Association of American Physicians, the American Society for Clinical Investigation, and the Institute of Medicine. He received a BS from Yale, a masters in Health Policy and Management from the Harvard University School of Public Health and a MD from Harvard Medical School.
Richard E. Kuntz, MD, MSc, is Senior Vice President and Chief Scientific, Clinical, and Regulatory Officer of Medtronic, Inc. in Minneapolis, MN. Prior to joining Medtronic, he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute, a university-based contract research organization which coordinates National Institutes of Health and industry clinical trials with the United States Food and Drug Administration. His major interests are traditional and alternative clinical trial design and biostatistics. He also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women’s Hospital in Boston.
Sharon Levine, MD, is Associate Executive Director for The Permanente Medical Group of Northern California; a large multi-specialty group practice in Oakland, CA within Kaiser Permanente’s integrated delivery system. A board-certified pediatrician, she has held multiple leadership roles with this group practice including Chief of Pediatrics. She held academic appointments at both Tufts University and Georgetown University Schools of Medicine and spent two years as a clinical associate researching infant nutrition at the National Institutes of Health’s Institute of Child Health and Human Development. She is a board member of the Reagan-Udall Foundation, Integrated Healthcare Association, and the Public Health Institute of California, and member of the California Medical Board. She is an adjunct associate for the Center for Health Policy/Center for Primary Care and Outcomes Research at Stanford University. She received a BA from Radcliffe College at Harvard University and a MD from Tufts University School of Medicine.
Freda Lewis-Hall, MD, is Executive Vice President and Chief Medical Officer for Pfizer Inc, the world’s largest research-based biopharmaceutical company. She leads Pfizer Medical, the division responsible for ensuring the safe, effective and appropriate use of Pfizer’s human health products, and directs regulatory and safety strategy and operations, medical information and medical affairs, and quality assurance and regulatory compliance. She was formerly Chief Medical Officer and Executive Vice President of Medicines Development at Vertex Pharmaceuticals; Senior Vice President of Medical Affairs at Bristol-Myers Squibb; Vice President of Research and Development at Pharmacia Corp.; and product team leader at Eli Lilly and Co., where she founded the Lilly Center for Women’s Health. Dr. Lewis-Hall serves on several boards, including The Institute of Medicine’s Forum on Drug Discovery, Development, and Translation; The Foundation for the National Institutes of Health; The Harvard Medical School Board of Fellows; the Society for Women’s Health Research; and the American Heart Association, Power to End Stroke. She is a fellow of the New York Academy of Medicine and the American Psychiatric Association. She received her BA from The Johns Hopkins University and her MD from Howard University College of Medicine.
Steven Lipstein, MHA, (vice chair) is President and Chief Executive Officer of BJC HealthCare in St. Louis, MO, a multi-hospital and health services organization with annual net revenues of $3.6 billion. Prior to joining BJC in 1999, he served as Executive Vice President at the University of Chicago Hospitals and Health System and held executive positions at The Johns Hopkins Hospital and Health System. He serves on the St. Louis Regional Health Commission and on the boards of Washington University in St. Louis, the Missouri Hospital Association, and Ameren Corporation, a public utility in Missouri & Illinois. He has served as chair of the Saint Louis Federal Reserve Bank. He received a BA from Emory University, a masters in health administration from Duke University, and completed a post-graduate fellowship in health services management at Massachusetts General Hospital.
Grayson Norquist, MD, MSPH, is Professor and Chairman, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center in Jackson, MS. His research focuses on the use of telemedicine to reduce disparities in mental health treatment for those living in the Delta region in Mississippi and to improve the quality of care they receive at local community health centers. He served in a number of leadership positions at the National Institute of Mental Health (NIMH), including Director of the Division of Services and Intervention Research, a division responsible for clinical, prevention and services research at NIMH. He was an associate clinical professor of psychiatry at Georgetown University. He is on the editorial board of Psychiatric Services, served on the editorial board of the Archives of General Psychiatry and the Journal of Mental Health Policy and Economics and received various national government and public awards, including the NIH Director’s Award, the NIH Special Service Award, and the National Alliance for the Mentally Ill Exemplary Psychiatrist Award. He received a BA from the University of Mississippi, a masters in public health from the UCLA School of Public Health and a MD from the University of Mississippi Medical Center.
Ellen Sigal, PhD, is Chair and founder of Friends of Cancer Research (www.focr.org), a cancer research think tank and advocacy organization based in Washington, DC. During the last twenty years, Dr. Sigal has been an advocate for finding new and better treatments for patients through advancing science and research. She has served on the National Cancer Institute Board of Scientific Advisors and the National Institutes of Health Director’s Council of Public Representatives. She was a presidential appointee to the National Cancer Advisory Board where she chaired the Budget and Planning Committee that oversees the federal cancer budget. She is currently Vice-chair of the Board of Directors of the Reagan-Udall Foundation for the FDA and Chair of the Public-private Partnerships Committee of the Foundation for the National Institutes of Health. She is a board member of the American Association of Cancer Research Foundation and Duke University Cancer Center. She received a BA and masters from Brooklyn College and a PhD from Rutgers.
Eugene Washington, MD, MSc, (chair) is the Vice Chancellor of UCLA Health Sciences and Dean of the David Geffen School of Medicine at the University of California Los Angeles in Los Angeles, CA. His major areas of research have focused on assessing medical technologies and national health policy, and have included prenatal genetic testing, cervical cancer screening and prevention, quality of health care, and racial/ethnic disparities in health outcomes. Prior to joining UCLA, he served as Executive Vice Chancellor and Provost and Professor of Gynecology, Epidemiology, and Health Policy at the University of California, San Francisco (UCSF). He served as chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at UCSF; director of the UCSF Women’s Reproductive Health Research Career Development Center; and co-founder and director of UCSF’s Medical Effectiveness Research Center for Diverse Populations. He also co-founded the UCSF-Stanford Evidence-based Practice Center and served as its first director. He worked for the Centers for Disease Control and Prevention (CDC) in the U.S. Public Health Service and received the Outstanding Service Medal from the U.S. Public Health Service. He is a member of the Institute of Medicine. He received a BS from Howard University, a MD from the UCSF School of Medicine, a MPH from the University of California, Berkeley School of Public Health, and a MSc from the Harvard University School of Public Health.
Harlan Weisman, MD, is Managing Director of And-One Consulting, LLC. He has over 20 years experience as a senior healthcare executive responsible for the discovery, development, regulatory approval and launch of innovative pharmaceutical, biopharmaceutical, medical device and diagnostic products. Harlan founded And-One Consulting, LLC to help organizations formulate and lead successful global strategies for medical product innovation. Harlan was previously Chief Science and Technology Officer of Medical Devices and Diagnostics (MD&D) at Johnson & Johnson and a member of the Board of Directors of J&J Development Corporation. His prior positions at J&J included Company Group Chairman, Pharmaceutical R&D and President of R&D at Centocor. Before joining Centocor, Harlan was Assistant Professor of Medicine at Johns Hopkins University School of Medicine and Director of the Experimental Cardiac Pathology Laboratory. He is a graduate of the University of Maryland and the University of Maryland School of Medicine. After residency in Internal Medicine at Mount Sinai Hospital in New York, he was a cardiovascular disease fellow at Johns Hopkins. Harlan is a Fellow of the American College of Cardiology, the American College of Chest Physicians, and the American Heart Association.
Robert Zwolak, MD, PhD, is a vascular surgeon at Dartmouth-Hitchcock Medical Center in Lebanon, NH and professor of surgery at the Dartmouth Medical School. He is also Chief of Surgery at the Veterans Administration Medical Center in White River Junction, VT, and director of the Non-invasive Vascular Laboratory. He has a special interest in health care policy issues and clinical outcomes science as they relate to vascular disease. He was instrumental in creating the Society for Vascular Surgery clinical outcomes data registry, formation of the professional society’s comparative effectiveness committee and most recently, introduction of a formal Patient Safety Organization. Currently serving as President of the Society for Vascular Surgery, he has held other positions of leadership including governor of the American College of Surgeons, chair of the ACS Socioeconomic Issues Committee, president of the New England Society for Vascular Surgery, and member of the SVS Board of Directors. He served on the AMA/Specialty Society Relative Value Update Committee and on the CMS Ambulatory Payment Category Panel. He received a BS from Rensselaer Polytechnic Institute, a PhD in molecular biology and pathology and a MD from Albany Medical College.